e-Drug3D

1718

TESTOSTERONE UNDECANOATE


INN
TESTOSTERONE UNDECANOATE

(has an active metabolite)

cas 5949-44-0
CLASS

GENITO
ANDROGEN INDICATED FOR TESTOSTERONE REPLACEMENT THERAPY IN ADULT MALES
CLIVAGE BY TISSUE ESTERASES
RAPIDLY HYDROLYZED IN TESTOSTERONE

ROUTE (list)

INTRAMUSCULAR ORAL

ATC code

G03BA03
G03EA02

PK parameters

Solubility

INSOLUBLE IN WATER


Target

TARGET ANDROGEN RECEPTOR

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17beta)-

Formula:
C30H48O3

Calculated chemical properties:

MW 456.68
NB_atoms 33
XLogP 7.96
PSA 41.224
NB_HD 0
NB_HA 3
fsp3 0.87
Lipinski(0=no;1=yes) 0

FDA
NDA 022219 (label) INN (TESTOSTERONE UNDECANOATE) AVEED (ENDO OPERATIONS) APPROVAL= AP YEAR= 2014
NDA 207583 (pdf not found) INN (TESTOSTERONE UNDECANOATE) TESTOSTERONE UNDECANOATE (PADDOCK LABS) APPROVAL= TA YEAR= 2016
NDA 206089 (label) INN (TESTOSTERONE UNDECANOATE) JATENZO (TOLMAR) APPROVAL= AP YEAR= 2019
NDA 208088 (label) INN (TESTOSTERONE UNDECANOATE) TLANDO (VERITY) APPROVAL= AP YEAR= 2022
NDA 213953 (label) INN (TESTOSTERONE UNDECANOATE) KYZATREX (MARIUS) APPROVAL= AP YEAR= 2022

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL